Improving medicines value for money in the NHS and the role of biosimilars - assessing progress so far

Research output: Contribution to conferencePosterpeer-review

2 Downloads (Pure)

Abstract

Biosimilars are essential to help contain medicine costs and treat patients well with biologicals.

Conference

ConferenceWestminster Health Forum policy conference
Period29/04/2129/04/21
Internet address

Keywords

  • biosimilars
  • NHS
  • procurement
  • Europe

Cite this